Clinical trial Recruiting at 1 site Observational Ages 18 and up

Predicting heart muscle scarring in patients with mitral valve prolapse

Official title: Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse: the SCIMITAR Trial

Run by Centro Cardiologico Monzino · NCT06341166 · Data updated 2026-11-12

This study is trying to find out if a new scoring system can help identify patients with mitral valve prolapse who are at risk for heart muscle scarring and related problems using heart imaging.

More Mitral Valve Prolapse trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorCentro Cardiologico Monzino
Academic / other
Locations1 site (Milan, Milan)
StatusRecruiting
StartedJune 19, 2023
Main results expectedOctober 19, 2026
Study endsOctober 19, 2026
Registry record updatedSeptember 21, 2026
Trial IDNCT06341166 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older with an echocardiographic diagnosis of mitral valve prolapse.

Probably not a fit

Patients under 18 years old or those with other significant heart conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter observational study aims to develop a scoring model to predict myocardial fibrosis in patients diagnosed with mitral valve prolapse (MVP) using cardiac magnetic resonance imaging. It will analyze both prospective and retrospective data to identify specific features that may increase the risk of ventricular arrhythmias or sudden cardiac death in these patients. The study seeks to clarify which patients with MVP should undergo cardiac magnetic resonance to detect potential myocardial fibrosis, which is currently uncertain in routine clinical practice.

Why it matters

Potential benefit: If successful, this study could lead to improved risk stratification and management of patients with mitral valve prolapse.

How similar studies have gone: Other studies have explored similar predictive models in cardiac conditions, but this specific approach to mitral valve prolapse and myocardial fibrosis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age ≥ 18 years
* Echocardiographic diagnosis of mitral valve prolaspe, defined as a systolic displacement of one or both mitral leaflets ≥ 2 mm above the plane of the mitral valve annulus in long-axis views

Exclusion Criteria:

* age\< 18 years
* coexistence of other cardiomyopathies or other ≥ moderate valve diseases
* scarce acoustic transthoracic echocardiographic window
* usual contraindications for cardiac magnetic resonance

Where it's running

  • Centro Cardiologico Monzino
    Milan, Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.